glp-1 gallbladder issues Risks with Weight Loss Medications Gallbladder Pain on GLP-1s: Symptoms

(2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 524 million UK adults

GLP-1 medications can suppress appetite, so under-eating becomes a real risk especially for people already conditioned to restrict

Pharmaceutical Executive

In COVID-19 patients, FeRD could trigger several clinical manifestations including (i) decrease functional hemoglobin (Hb), (ii) increase cellular iron overload, (iii) release free toxic heme into the circulation, (iv) manifest hypoxemia and systemic hypoxia, (v) reduce nitric oxide (NO) synthesis, (vi) activate coagulation pathway(s), (vii) trigger ferroptosis with OxS and lipid peroxidation, and (viii) induce mitochondrial degeneration 27,146

Clinical studies have shown that Vit C deficiency among PD patients with PD is widespread, and intracellular Vit C seems to be associated with PD